Protein,Protein_definition,Disease_category,Disease,Method,Nb_SNP,OR[95%CI],P_value
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",Inverse variance weighted,55,1.02 [0.96-1.07],0.589197052515159
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,Inverse variance weighted,55,1.03 [0.80-1.32],0.822018546866975
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",Inverse variance weighted,55,1.00 [0.98-1.02],0.982946191290469
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Early onset COPD,Inverse variance weighted,55,1.00 [0.97-1.04],0.819423627071498
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,Inverse variance weighted,55,1.00 [0.98-1.02],0.991608126180839
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,Inverse variance weighted,55,1.00 [0.99-1.02],0.688993141888045
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,Inverse variance weighted,55,1.01 [0.99-1.02],0.33885394253033
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,Inverse variance weighted,55,1.05 [0.98-1.11],0.154434131643606
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,Inverse variance weighted,55,0.99 [0.97-1.01],0.286308564223966
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,Inverse variance weighted,55,0.98 [0.96-1.00],0.023012308550295
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",Inverse variance weighted,55,1.00 [0.98-1.02],0.914515256892725
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Hypertension,Inverse variance weighted,55,1.00 [0.99-1.02],0.565388780341167
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",Inverse variance weighted,55,0.99 [0.97-1.00],0.096008373105793
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,Inverse variance weighted,55,0.99 [0.97-1.01],0.316327812332358
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,Inverse variance weighted,55,0.99 [0.93-1.06],0.797678927531603
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",Inverse variance weighted,55,1.00 [0.99-1.02],0.687918619656718
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,Inverse variance weighted,55,1.00 [0.99-1.02],0.60455042799251
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,Any mental disorder,Inverse variance weighted,55,0.99 [0.98-1.01],0.318700036319768
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,Inverse variance weighted,55,1.01 [1.00-1.02],0.20639159329304
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",Inverse variance weighted,55,1.00 [0.99-1.02],0.777515301251578
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,Inverse variance weighted,55,1.01 [0.99-1.03],0.325154499288359
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,Inverse variance weighted,55,1.01 [0.99-1.04],0.356715219072386
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,Inverse variance weighted,55,1.01 [1.00-1.03],0.153792843222082
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,Inverse variance weighted,55,1.01 [0.98-1.04],0.421306690073829
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,Inverse variance weighted,55,0.99 [0.96-1.02],0.498889505363578
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,Inverse variance weighted,55,0.97 [0.93-1.02],0.256300989481757
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",Inverse variance weighted,55,0.99 [0.95-1.04],0.731131977268379
